rs104894382
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_181486.4(TBX5):c.709C>T(p.Arg237Trp) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R237Q) has been classified as Pathogenic.
Frequency
Consequence
NM_181486.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBX5 | NM_181486.4 | c.709C>T | p.Arg237Trp | missense_variant | Exon 7 of 9 | ENST00000405440.7 | NP_852259.1 | |
TBX5 | NM_000192.3 | c.709C>T | p.Arg237Trp | missense_variant | Exon 7 of 9 | NP_000183.2 | ||
TBX5 | NM_080717.4 | c.559C>T | p.Arg187Trp | missense_variant | Exon 6 of 8 | NP_542448.1 | ||
TBX5 | XM_017019912.2 | c.757C>T | p.Arg253Trp | missense_variant | Exon 7 of 9 | XP_016875401.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBX5 | ENST00000405440.7 | c.709C>T | p.Arg237Trp | missense_variant | Exon 7 of 9 | 1 | NM_181486.4 | ENSP00000384152.3 | ||
TBX5 | ENST00000310346.8 | c.709C>T | p.Arg237Trp | missense_variant | Exon 7 of 9 | 1 | ENSP00000309913.4 | |||
TBX5 | ENST00000349716.9 | c.559C>T | p.Arg187Trp | missense_variant | Exon 6 of 8 | 1 | ENSP00000337723.5 | |||
TBX5 | ENST00000526441.1 | c.709C>T | p.Arg237Trp | missense_variant | Exon 6 of 7 | 1 | ENSP00000433292.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Holt-Oram syndrome Pathogenic:2
- -
- -
Aortic valve disease 2 Pathogenic:1
This variant has been reported in individuals affected with Holt–Oram syndrome (PMID: 10077762, 12789647) and in a family affected with congenital heart defects (PMID: 25931334). ClinVar contains an entry for this variant (Variation ID: 7995). This missense change locates in the T-box domain of TBX5 and has been shown in experimental studies to affect TBX5 DNA-binding and TBX5 interaction with NKX2-5, resulting in reduced activation of downstream targets (PMID: 20519243, 12499378, 16380715). This variant disrupts the p.Arg237 amino acid residue in TBX5. Other variant(s) that disrupt this residue have been observed in affected individuals (PMID: 10077612, 12499378, 20519243), suggesting that it is a clinically significant residue. As a result, variants that disrupt this residue are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with tryptophan at codon 237 of the TBX5 protein (p.Arg237Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. -
Heart, malformation of Pathogenic:1
- -
Cardiovascular phenotype Pathogenic:1
The p.R237W pathogenic mutation (also known as c.709C>T), located in coding exon 6 of the TBX5 gene, results from a C to T substitution at nucleotide position 709. The arginine at codon 237 is replaced by tryptophan, an amino acid with dissimilar properties. This variant was initially reported in two probands with Holt-Oram syndrome (Brassington AM et al. Am J Hum Genet, 2003 Jul;73:74-85). This variant has also been detected in individuals and families with atrial and ventricular septal defects (Ambry internal data; Jia Y et al. Am J Med Genet A, 2015 Aug;167A:1822-9). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is predicted to be deleterious by in silico analysis. Another alteration at the same codon, p.R237Q (c.710G>A) has also been described in individuals with Holt-Oram syndrome (Basson CT et al. Nat. Genet., 1997 Jan;15:30-5; Debeer P et al. Clin. Orthop. Relat. Res., 2007 Sep;462:20-6; Vanlerberghe C et al. Eur. J. Hum. Genet., 2019 03;27:360-368). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at